AFYREN’s Shareholders Approve All Resolutions Proposed at 2022 Annual General Meeting
16 Juin 2022 - 8:00AM
Business Wire
- Patrizia Marraghini and Caroline Lebel approved as new Board
directors
- 75.18% of the Company’s share capital was represented at the
AGM, and all resolutions were approved by large margins
Regulatory News:
AFYREN (Paris:ALAFY), a greentech company that manufactures
biobased ingredients using fermentation technology and a circular
business model, today announced that its shareholders have approved
all of the resolutions proposed at its Annual General Meeting (AGM)
of June 15, 2022.
On first call, the necessary quorum was reached, the
shareholders having voted represent 75.18% of the share capital and
75.36% of the voting rights of the company. They approved all the
resolutions. Detailed results are available on the AFYREN website:
https://afyren.com/en/investor/
These resolutions include the approval of the appointments to
the Board of Directors of Patrizia Marraghini as independent
Director and Chairwoman of the Audit Committee, and of Caroline
Lebel as Director.
AFYREN thanks all the shareholders who have participated and
welcomes the arrival of Mrs. Marraghini and Mrs. Lebel, who
reinforce the competence and independence of its Board of
Directors.
Stefan BORGAS, Chairman of the Board of Directors,
stated: "We are delighted to welcome Caroline and Patrizia to
the AFYREN Board of Directors. Their experience will bring a wide
range of key skills and contribute to the positive dynamic of the
Company. These new appointments are part of a strong strategy of
diversification of governance through which we hope to achieve a
balance in the short-to-medium term. Meanwhile, AFYREN’s
development continues to gather momentum, notably with the
finalization of construction at its first plant and a listing on
the stock exchange that will pave the way for its international
deployment. Upcoming industrial projects underscore the company’s
ambition and its ability to operate in the field in keeping with
current trends, while meeting the need to develop more efficient
and sustainable industry."
Watch exclusive interviews with Patrizia
Marraghini and Caroline Lebel
About AFYREN
Founded in 2012 to meet the growing need of industries to reduce
the use of petroleum derivatives in their production chain, AFYREN
produces biomolecules derived from the reuse of non-food biomass.
These ingredients are widely used in human and animal nutrition,
flavors and fragrances, cosmetics, and fine chemicals. This
production of renewable carbon, which is firmly grounded in the
circular economy, uses fermentation technologies that are the
result of 10 years of research and are patented worldwide. AFYREN
is a winner of the 2030 Global Innovation Contest in the "Plant
proteins and plant chemistry" category and was selected in the
French Tech 120 in 2020 and 2021. In 2018, AFYREN committed to its
industrial project by creating the AFYREN NEOXY joint venture with
Bpifrance’s SPI fund. The AFYREN NEOXY plant under construction in
the Grand Est region will produce AFYREN organic acids in 2022.
AFYREN and AFYREN NEOXY employed more than 70 people at their sites
in Lyon, Clermont-Ferrand and Carling Saint-Avold. In 2021, AFYREN
listed on Euronext Growth® exchange in Paris, raising a total
amount of 70.4 million euros with the objective of accelerating its
industrial development (Afyren's ISIN: FR0014005AC9, ticker:
ALAFY).
For more information: afyren.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220615005928/en/
Investors: investisseurs@afyren.com Press: James Connell -
Bogert-Magnier Communications (+33 6 2152 1755);
jim@bogert-magnier.com
Afyren (EU:ALAFY)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Afyren (EU:ALAFY)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024